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Key Points: 
 
• Weibel-Palade bodies (WPBs) contain CD63-positive intraluminal vesicles that are released 
during secretagogue-evoked exocytosis. 
• Cryo-electron microscopy of intact vitrified endothelial cells reveal intraluminal vesicles as 
a novel structural feature of WPBs.  
 
 
Abstract 
Weibel-Palade bodies (WPBs) are secretory granules that contain von Willebrand factor and P-
selectin, molecules that regulate hemostasis and inflammation respectively. The presence of 
CD63/LAMP3 in the limiting membrane of WPBs has led to their classification as lysosome-related 
organelles. Many lysosome-related organelles contain intraluminal vesicles (ILVs) enriched in 
CD63 that are secreted into the extracellular environment during cell activation to mediate 
intercellular communication. To date there are no reports that WPBs contain or release ILVs. By 
light microscopy and live-cell imaging we show that CD63 is enriched in micro-domains within 
WPBs. Extracellular antibody recycling studies showed that CD63 in WPB micro-domains can 
originate from the plasma membrane. By cryo-electron tomography of frozen-hydrated endothelial 
cells we identify internal vesicles as a novel structural feature of the WPB lumen. By live-cell 
fluorescence microscopy we observe directly the exocytotic release of EGFP-CD63 ILVs as 
discrete particles from individual WPBs. WPB exocytosis provides a novel route for release of 
ILVs during endothelial cell stimulation.  
 
Key Words:  electron cryomicroscopy, endothelial cells, Weibel-Palade body, intra-luminal vesicle, 
von Willebrand factor, exosome, CD63, P-selectin. 
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Introduction  
Endothelial cells regulate hemostasis and inflammation through direct cell-cell contacts, secretion 
of soluble or membrane associated mediators, and through the release of small bioactive lipid 
vesicles (extracellular vesicles; EVs). Many of the soluble secreted molecules, such as the adhesive 
glycoprotein von Willebrand Factor, are stored and released in a regulated fashion from specialized 
secretory granules called Weibel-Palade bodies (WPBs) 1. EVs can arise by several distinct 
mechanisms: (1) exocytosis of late endosomes/multivesicular bodies (LE/MVBs) to release intra-
luminal vesicles (ILVs; termed exosomes upon secretion) (2) budding from the plasma membrane 
(shedding micro-vesicles or ecotosomes), or (3) plasma membrane blebbing during programmed 
cell death (apoptotic bodies). EVs contain a variety of signaling molecules that modulate gene 
expression and function of target cells, and are now widely viewed as important mediators of 
intercellular communication and control 2. 
 
WPBs form at the trans-Golgi network (TGN) through a pH- and Ca2+-dependent condensation of 
von Willebrand factor (VWF) and the VWF-propolypeptide (VWFpp) to form helical tubule 
structures 3-5. VWF-VWFpp tubules comprise the majority of the protein content of WPBs and give 
the organelle its distinctive morphology 3. The leukocyte adhesion molecule P-selectin is also stored 
in the WPB limiting membrane and upon release into the plasma membrane it mediates the 
tethering and rolling of leukocytes on the vessel wall prior to extravasation at sites of inflammation. 
Efficient P-selectin-mediated leukocyte capture requires the tetraspanin CD63 (also called LAMP3) 
that is also present in the limiting membrane of WPBs and co-released to the plasma membrane 
during exocytosis 6-8. P-selectin enters WPBs during their formation at the TGN, however, CD63 is 
delivered to WPBs at a later stage through a poorly defined interaction with LE\MVBs 9,10 requiring 
the endosomal sorting complex AP-3 and annexin 8 7,10. 
The interaction of WPBs with endosomal components, their acidic lumenal pH, and acquisition of 
CD63/LAMP3 have led to the WPBs classification as a lysosomal-related organelle (LRO) 11, a 
       
 
      Intra-luminal vesicles of WPBs  
 
4 
 
functionally diverse set of compartments containing different cargoes that none-the-less share 
certain features or components with lysosomes. LRO biogenesis is complex and organelle-specific: 
Some form by re-modeling/maturation of endosomal compartments (e.g. MVBs, secretory 
lysosomes, melanosomes), some originate from the TGN (WPBs), while others may involve 
contributions from both pathways (e.g. lytic granules, platelet granules) 11. 
LROs that undergo fusion with the plasma membrane to release their contents include the major 
histo-compatibility complex class II-enriched compartment of B lymphocytes, lytic granules of 
cytotoxic T cells, platelet dense core and α-granules, basophilic granules, lamellar bodies of lung 
epithelia cells, osteoclast granules, sperm acrosomes and WPBs 12,13. In most cases the delivery of 
these organelles to the plasma membrane, and their exocytosis, is regulated by “secretory Rab 
proteins” and their effector molecules. For WPBs, these include Rab27A, MyRIP, Slp4-a and 
Munc13-4 14-17.  Some LRO’s contain ILVs that can be released during fusion with the plasma 
membrane 12,18,19, and unsurprisingly several key regulators of WPB and other LRO exocytosis (e.g. 
Rab27A, Slp4-a) also control exosome release 20,21. Despite their classification as LROs and sharing 
a common set of molecular components regulating exocytosis, it is not known whether WPBs 
contain or release ILVs. 
Using live-cell imaging and high-resolution cryo-EM tomography of vitrified endothelial cells we 
identify and characterize ILVs in WPBs. We directly demonstrate the exocytotic release of EGFP-
CD63 enriched ILVs from individual WPBs during hormone-stimulation. This is a new route for 
EV release from endothelial cells and extends the range of signaling modalities through WPBs. 
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Methods 
 
Endothelial cell culture, transfections, immunocytochemistry, antibodies, DNA constructs and 
reagents 
 Human umbilical vein endothelial cells (HUVEC) or human heart microvasculature 
endothelial cells (HHMEC) were purchased, cultured, Nucleofected and processed for 
immunocytochemistry as previously described 15,22. VWF-mRFP or -mCherry, VWFpp-mRFP, 
VWFpp-mEGFP, mRFP-Rab27A and EGFP-CD63 have been described previously (see 15 and 
references therein). Rabbit anti-VWF (A0082, 1:10000 dilution) was from Dako Ltd (Ely, UK), 
rabbit anti-VWFpp (1:500) is described in 23, mouse anti-LBPA (Z-PLBPA, 1:1000) was from 
Tebu-bio (Peterborough, UK), mouse anti-P-selectin (clone AK6, 1:50) was from Serotec 
(Kidlington, UK), rabbit anti-VPS2B (ab33174, 1:300) and mouse anti-Alix (ab117600, 1;300) 
were from Abcam (Cambridge, UK), rabbit anti-syntenin (133003, 1:100) was from Synaptic 
Systems GmbH (Gottingen, DE), mouse anti-TSG101 (GTX70255) and rat anti-HSP70 
(GTX191366) were from GeneTex (Irvine, CA), mouse anti-CD9 (clone HI9a, 1:1000), anti-CD81 
(clone 5A6, 1;1000) were from Biolegend (London, UK), mouse anti-CD63 (clone H5C6, 1;200) 
was from the Developmental Studies Hybridoma Bank (see Acknowledgments), normal mouse 
IgG1 (SC-3877, 1;55) and mouse anti-CD63-TRITC (SC-5275, 1:55) were from Insight 
Biotechnology ltd (Wembly, UK), from Abcam. Secondary antibodies coupled to fluorophores 
(1:200) were from Jackson Immunoresearch (USA). All other reagents were from Sigma-Aldrich 
unless otherwise stated.  
 
Cell culture on electron microscopy grids, electron cryomicroscopy and image and tilt series and 
tomogram analysis. 
HUVEC or HHMEC were grown on carbon film on gold grid supports for microscopy as 
previously described 3.  Gold grids with cells on were washed briefly in PBS and 4 µl of 40% 
protein A conjugated 10nm gold colloid (BBI Life Sciences) in PBS added between washing and 
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freezing, to act as fiducial markers. WPBs were imaged in cells either unstimulated or following 
stimulation. For stimulation PBS contained 100 µM histamine dihydrochloride or  ionomycin 
(300nM or 1 µM ionomycin, Streptomyces conglobatus).  
Grids were frozen by plunging into liquid ethane using either a manual plunge-freezer or an FEI 
Vitrobot Mark III (FEI Company) at either at room temperature and humidity (manual) or at 22°C 
and room humidity (Vitribot; humidifier switched to off). Frozen grids were stored in liquid N2.  
Frozen grids were imaged using either a Spirit TWIN microscope (FEI) operating at 120 kV and 
equipped with an Eagle 2k camera (FEI) using a Gatan 626 cryotomography holder or a LN2 cooled 
Polara microscope (FEI) operating at 200 kV and equipped with a F224 CCD camera (TVIPS). 
Both TIA (FEI) and SerialEM [63] image acquisition software were used, and low-dose procedures 
were used in both packages. SerialEM was used to collect whole grid montages at ~140x 
magnification, which were used for locating areas of interest for further imaging using low-dose 
procedures. 
Single-axis tilt-series were collected automatically using SerialEM, with an angular range of -60° to 
+60° and increment of 2° or 3°. Total dose for tilt-series were limited to 50  to 70 e-/A2, giving 
individual images with a dose of 1.2 to 1.7 e-/A2. The dose per image was kept constant for each tilt 
angle in a series. The target defocus was set at -8 µm. Tomographic tilt series were aligned using 
fiducials using Etomo from the in IMOD software 24. Projection images in aligned tilt series were 
normalized based on their histograms and reconstructed to 3D volumes and analyzed as previously 
described 3. 
 
Image and volume analysis. 
Simple image processing tasks such as crop, pad and rotate were performed in 
Ximdisp and FFT calculations were performed using Ximdisp and _trans from 
the MRC suite.  Figures were prepared using Photoshop CS4 (Adobe). Amira (FEI Visualization 
Sciences Group), and IMOD were used to generate 3D models. 
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VWF tubules were manually traced using IMOD. Tomograms were segmented using the Amira 
‘Segmentation' tool. Membranes and tubules were rendered and displayed in Amira. 
 
Live cell fluorescence imaging, confocal FRAP and analysis. 
Nucleofected cells were plated at confluent density in culture medium onto 35 mm diameter poly d-
lysine coated glass glass-bottomed culture dishes (MatTeK corp. Ashland, USA) or 25 mm 
diameter glass coverslips (#1.0, 0.15 mm, VWR International, UK). 25 mm diameter glass 
coverslips were mounted in Rose chambers containing physiological saline (in mM): NaCl- 140, 
KCl- 5, MgSO4- 1, CaCl2- 2, Glucose- 10, HEPES- 20, pH 7.3 (adjusted with NaOH). High speed 
dual-color epifluorescence imaging was carried out on an Olympus IX71 inverted microscope 
equipped with an Olympus UPLSAPO x100 oil 1.40NA objective, a 1.6x magnifier and an Ixon3 
EMCCD camera operated in frame transfer mode at full gain and cooled to –70ºC (Andor, Belfast, 
United Kingdom). Full frame images were acquired at 30 frames s−1. High-speed single or 
sequential dual color excitation wavelength switching (470±40nm and 572±35nm) was by 
OptoLED (Cairn Research, Faversham, UK), the excitation filter set comprising a GFP/DsRed dual 
band dichrochic mirror (Chroma part 51019) and a GFP/DsRed dual band emitter. Image capture 
and wavelength switching was synchronized using WinFluor software (Dr John Dempster, 
Strathclyde University, Glasgow, United Kingdom). The microscope was housed within an 
environmental chamber maintained at 36oC and cells stimulated with histamine (100µM). Confocal 
FRAP experiments were carried out using Leica Microsystems TCS SP2 or SP5 (8 kHz resonant 
scanner) confocal microscopes equipped with Leica HCX PL APO x63 1.32NA (SP2) or HCX 
PLAPO CS x100 oil-immersion objectives with NA of 1.40 (SP2) or 1.46 (SP5) as previously 
described 15,25,26. Excitation (bidirectional “fly” FRAP mode) was at 488nm (EGFP) and 561nm 
(mRFP). Emission windows for single-wavelength (EGFP) were 495-620nm and for dual-colour 
(EGFP, mRFP; simultaneous “fly” mode excitation) were, EGFP;500-545 nm, mRFP;585-750nm.  
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Images from SP2 were collected at 512x128 (or 64) pixels and at zooms 20-32, and from SP5 at 
512x300 pixels at zooms between 19.1 and 38.8. FRAP imaging and ROIs were set as previously 
described 15,25,26 and single or dual-color bleaching applied during 2-10 consecutive frames acquired 
at 0.344 seconds (SP2) and between 0.792 and 0.962 was seconds (SP5). Images were background-
subtracted and analyzed using custom-made macros implemented in ImageJ 
(http://rsb.info.nih.gov/ij/) 26. Image montages and AVI video clips (Jpeg compression) were made 
in ImageJ2\Fiji.  Data plots were made in Origin 9.2 (OriginLab Corporation, Northampton, USA).  
Results are expressed as mean ± s.e.m.  
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Results 
Enrichment of CD63 in discrete micro-domains within WPBs 
Tetraspanins, including the ubiquitously expressed CD63, are amongst the most common 
endosomal components enriched in secreted ILVs 27,28 (http://www.exocarta.org/), and CD63 in 
particular is implicated in cargo sorting to exosomes 29. Consequently CD63 is widely used as a 
marker to identify, visualize and track ILVs/exosomes within and between cells 30. To determine if 
WPBs contained CD63-enriched regions we first analyzed the pattern of endogenous CD63 in 
WPBs by immunocytochemistry (Figure 1A). Consistent with previous studies CD63-
immunoreactivity was seen on both WPBs and other endomembrane compartments 31. Close 
inspection revealed discrete bright “micro-domains” of CD63-immunoreactivity associated with 
some WPBs, often near the ends of the organelle but also at intermediate points up to mid-body 
(Supplementary Figure S1A). Expression of EGFP-CD63 produced similar features (Figure 1B), 
and crucially, live-cell fluorescence imaging showed that the EGFP-CD63 micro-domains were 
connected to and moved with (but not within) the WPB (See Supplementary videos S1 and S2). 
Measurement of WPB EGFP-CD63 fluorescence intensity in live cells showed the micro-domains 
to be stable in intensity and up to 4-5 times brighter than the bulk signal in the WPB membrane 
(Figure 1C), reminiscent of the enrichment reported for CD63 in ILVs of LE/MVBs and exosomes 
32
. Further immunofluorescence analysis showed that other WPB membrane proteins (Rab27A, P-
selectin) were present in the limiting membrane of the granule but were not concentrated in CD63-
rich micro-domains (Supplementary Figure S1B). 
At the plasma membrane, tetraspanins can form enriched areas or microdomains that appear as 
long-lived “spot-like” structures in which contributing tetraspanins, and associated proteins, are in 
dynamic exchange with the bulk plasma membrane on a time scale of seconds 33. To examine if 
EGFP-CD63 in the WPB limiting membrane was in diffusional equilibrium with CD63 
microdomains we used single WPB FRAP analysis in EGFP-CD63 and VWF-mRFP co-expressing 
HUVEC 25,26. Consistent with our previous studies25 EGFP-CD63 was freely mobile in the WPB 
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limiting membrane, undergoing rapid and complete recovery, by lateral membrane diffusion, after 
each period of bleaching (Supplementary Figure S2, and Supplementary video S3). The core protein 
VWF-mRFP was used to confirm the organelle’s identity, and was completely immobile showing 
no recovery after bleaching, as previously reported 25. Our FRAP analysis showed that EGFP-CD63 
in micro domains did not contribute to recovery of EGFP-CD63 fluorescence within the limiting 
membrane nor did micro domains re-accumulate fluorescence from the WPB limiting membrane 
when selectively bleached (Supplementary Figure S2). The results indicate that EGFP-CD63 in 
microdomains is not in diffusional equilibrium with EGFP-CD63 in the WPB limiting membrane.  
 
Intra-luminal vesicles in WPBs revealed by cryo-electron tomography 
The presence of micro-domains containing the membrane tetraspanin CD63 but topologically 
separated from the WPB membrane suggested that these were ILVs. To test this we applied high-
resolution electron cryomicroscopy to image the thin edge of plunge-frozen, whole mount HUVECs, 
an approach that we have previously shown to reveal the high-resolution architecture of organelles 
without chemical fixation or staining 3.  In 2D projection images, WPBs appear as rod-shaped 
granules denser than the surrounding cytoplasm (Figure 2A-C) containing tubules of VWF which 
are the source of the signature helical pattern in their Fourier transforms (Figure 2B, inset). We can 
identify ILVs in these images (arrows). In fact, 12% of 535 2D images show evidence for at least 
one and up to three ILV’s per granule. To clearly identify the internal vesicles in the context of 
granule architecture without the ambiguity of overlap in the 2D image, we performed electron 
cryotomography and volume reconstruction. Figure 3 (and Supplementary video S4) shows a 
tomogram section containing WPBs, other vesicular organelles, cytoskeletal filaments, ribosomes, 
and other particles. ILVs within WPBs are indicated by arrows. The lumen of WPB ILVs was less 
electron dense than the surrounding VWF tubules, being similar in density to the lumen of ILVs of 
MVBs and to regions of cell cytosol. 
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We built structural models for 22 ILVs from 15 tomograms (Figures 4, 5 and Supplementary Figure 
S3). ILVs were not confined to regions close to the ends of WPBs, but could be seen at any point up 
to mid-body. In many cases the membrane of the ILV was in close apposition to the WPB limiting 
membrane and sometimes associated with a bulge in the WPB limiting membrane. ILVs were often 
non-spherical in shape, appearing compressed between the smooth limiting membrane of the WPB 
and VWF tubules. As previously observed WPBs contained paracrystals of helical VWF, shown in 
cross section as indicated in Figure 4A and Supplementary video S5. A prominent membrane-
bounded ILV can be seen where the paracrystalline packing is disrupted giving the granule a club-
shape, a common morphology for WPBs. WPB ILVs were also observed in adult human heart 
microvascular endothelial cells (HHMEC) (Figure 4B and Supplementary Figure S3C) confirming 
that these structures are not specific to HUVEC but represent a general feature of endothelial WPBs.  
 
We observed many WPB ILVs of HUVEC or HHMEC to contain densities and structures 
resembling cytoplasmic components (Figure 4 B,C and Supplementary Figure  S4 and video S6). 
Measurements of WPB ILVs and ILVs of single- and multi-vesicular bodies (MVBs) and single 
internal vesicle bodies in tomograms (Figure 5) showed them to have a similar size distribution and 
include some large outliers (e.g. ILV in WPB in Supplementary Figure S3A). The majority of ILVs 
in WPBs (mean volume 147,292±41,225 nm3, sem, n=15 measurements) are similar in size to the 
small vesicles within the MVBs (mean volume 165,286±30,664 nm3, sem, n=25) (see 
Supplementary video S7).  
 
WPB ILVs contain CD63 derived from the endocytic pathway but may differ in composition 
from ILVs in MVBs 
Because endogenous CD63 cycles from the plasma membrane to WPBs via the endocytic pathway 
7,9,10
 we next examined whether CD63 in WPB ILVs was also derived from this trafficking route by 
monitoring the accumulation of an extracellularly applied TRITC-labelled mouse anti-human CD63 
       
 
      Intra-luminal vesicles of WPBs  
 
12 
 
antibody in WPBs as previously described 7 (Figure 6). The TRITC-anti-CD63 antibody (but not a 
non-targeting mouse IgG1 control antibody, Supplementary Figure S5) was readily trafficked to 
WPBs (Figure 6A) and in both control and EGFP-CD63-expressing HUVEC was enriched within 
WPB ILVs (Figure 6B-C) confirming that WPB ILV CD63 is of endosomal origin. We next looked 
for evidence in WPB-ILVs of other components reported to be present in ILVs of endosomal origin. 
Biochemical studies have identified cholesterol as one of the lipids enriched in exosomes 34. 
Localization of cholesterol-rich regions by filipin staining in HUVEC, showed abundant labelling 
of endosomal/lysosomal structures but no labelling of WPBs (Supplementary Figure S6C). Some 35 
but not all 36 studies suggest that LE/MVBs and their ILVs are enriched in lysobisphosphatidic acid 
(LBPA).  Immuno-staining of HUVEC for endogenous LBPA, showed a striking punctate 
enrichment within LE/MVBs but no labelling of WPBs (Supplementary Figure S6Ai), a result 
consistent with a previous study 9. The fluorescent phosphatidyl ethanolamine (PE) analogue, N-
Rh-PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[lissamine rhodamine B sulfonyl]), 
is taken up from the plasma membrane, trafficked to LE\MVBs and incorporated into exosomes 37,38. 
Incubation of HUVEC with N-Rh-PE revealed no WPB staining (Supplementary Figure S6Bi-ii). 
Other common exosomal markers, including CD9, CD81, along with several ESCRT components 
including Alix, TSG101, VSP2/Chmp2B, HSP70 and the autophagy marker LC3 were not detected 
in WPBs (Supplementary Figures S7 and S8). However, we did detect the PDZ domain containing 
adapter protein, syntenin, associated with WPBs (Supplementary Figure S8B). Together the results 
suggest WPB ILVs have a distinct composition.  
 
 
Direct observation of ILV secretion during WPB exocytosis  
 
Having established that WPBs do contain ILVs we next asked whether these could be released 
during exocytosis. If so, we predicted that WPB associated EGFP-CD63 microdomains (ILVs) 
would be released as discrete fluorescent particles during WPB exocytosis. To test this we 
monitored histamine-evoked WPB exocytosis in live HUVEC co-expressing VWF-mCherry and 
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EGFP-CD63 using high-speed epifluorescence imaging. EGFP-CD63 labeled ILVs were released 
as discrete particles from individual WPBs during histamine stimulation (Figure 7). Panels A-D 
show image sequences taken from Supplementary videos S8, S9, S10 and S11 respectively. In 
examples A-C the EGFP-CD63 particles (arrows) escape rapidly into the bulk solution and are lost 
from view. D shows an example of the particle becoming trapped within the extracellular patch of 
VWF secreted during WPB exocytosis. In addition to direct release into the bulk solution the 
particles were also secreted into the narrow two-dimensional plane between the cell and the glass 
coverslip. In these cases the extracellular diffusion of the particles could be visualized for long 
periods before the particles eventually encountered the cell edge and escaped into the bulk media 
(e.g. Supplementary video S12). Consistent with our ultrastructural data, we also observed release 
of multiple ILVs from single WPB (Supplementary video S13). Thus CD63-containing ILVs are 
released from the interior of the WPB to the extracellular medium along with VWF during 
exocytosis. 
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Discussion 
Here we demonstrate that WPBs contain CD63-postive ILVs and release them during secretagogue-
evoked exocytosis. Shedding of plasma membrane-derived vesicles and MVB-plasma membrane 
fusion has been visualized in live cells 21,39,40, however, direct imaging of ILV release from 
individual regulated secretory granules during exocytosis has not been reported previously.  To 
indicate their specific origin, we refer to the secreted vesicles described here as WPB-released 
exosomes.  
 
Our cryomicroscopy studies of the thin periphery of endothelial cells show that mature WPBs 
contain ILV’s that are either embedded within and distort the paracrystalline assemblies of VWF 
tubules or are squeezed between the VWF paracrystal and the tightly wrapped granule-limiting 
membrane. This accounts for their immobility within the granule.  
 
During exocytosis WPB-released exosomes are secreted into the surrounding medium, although 
they may initially be entangled by the secreted VWF. In other systems, tethering has been proposed 
as a mechanism of restricting exosomes to local target sites 41. WPB exocytic events involve 
complex structural changes in the granule 1 and may selectively release small molecules to the 
bloodstream as well as CD63 to the plasma membrane without releasing VWF 42. ILV release adds 
an additional signaling diversity to these exocytic events. 
 
The identification of CD63-rich ILV’s within the WPB lumen extends the features that WPBs share 
with other LROs. Many LROs, such as melanosomes and lytic granules, release CD63-rich vesicles. 
Our observations draw further attention to the similarity of WPBs to platelet α-granules which 
originate as MVBs containing ILVs, but during maturation become filled with dense material, 
including VWF and P-selectin. In addition, our immunofluorescence data show that WPB ILVs are 
enriched in CD63 but lack CD9 or CD81, which is also the case with the ILVs of platelet α-
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granules 18.   
In contrast to platelet α-granules, WPBs form by the polymerization of VWF in nascent granules at 
the TGN. Protrusive clathrin-coated membrane buds are a feature of nascent WPBs, reflecting the 
active sorting away of material not destined for storage in the mature WPB 43. Mature WPBs lack 
bilayer coats 3,43,44 and our cryo-EM images of vitrified endothelial cells show a tight, almost shrink 
wrapped limiting membrane surrounding the paracrystalline core of VWF and associated ILVs. 
Newly forming WPBs emerging from the TGN lack CD63, but soon after acquire the tertraspannin 
through a poorly defined interaction with endosomal components 9,10 that involve the adapter 
protein AP3 and Annexin 8 7,10. These observations (on WPBs and platelet α-granules) contribute to 
a view in which the LRO possesses a mixture of endosomal vs regulated secretory features that 
depend on the organelle’s biogenesis and specialisation. 
 
In this study we have shown that the CD63 in WPB ILVs is trafficked via the endosomal system. 
CD63 is a ubiquitously expressed integral membrane protein found on the plasma membrane and 
endosomal compartments of all cells 45. In endosomal compartments CD63 is enriched in a subset 
of ILVs and is present on exosomes secreted during MVB fusion with the plasma membrane 34,46,47. 
CD63 delivery to WPBs could occur through small vesicles formed by endosomal membrane 
budding 48. Such vesicles can contain AP3 49, the adapter protein implicated in CD63 delivery to 
WPBs 10. Alternatively, direct fusion and content transfer between LE\MVBs and lysosomal 
compartments is well documented 50 and a similar process could account for diffusional transfer of 
CD63 to the limiting membrane of the maturing WPB, as well as direct MVB to WPB ILV transfer. 
The absence in WPBs of several markers reported to be enriched in ILVs/exosomes of LE/MVBs; 
Lysobisphosphatidic acid (LPBA) 9, cholesterol 36, CD9 and CD81 32,45, as well as exogenous 
markers reported to accumulate in LE/MVB ILVs; N-Rh-PE 37, indicate that WPB ILVs may 
represent a distinct population with similarities to those of platelet α-granules. 
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We looked for the presence of ESCRT components and associated proteins known to be involved in 
MVB exosome formation and found syntenin localized to WPBs. Syntenin is a cytosolic PDZ 
domain protein that acts as an intracellular adapter involved in many processes including exosome 
biogenesis and secretion 51. Syntenin binds directly to CD63 52 and regulates formation of CD63-
containing exosomes 51,53. The localization of CD63 and syntenin on WPBs, the presence of 
cytoplasmic components within WPB ILVs may indicate formation of WPB ILVs by inward 
budding of the WPB limiting membrane during organelle maturation. 
 
Growing evidence suggests that endothelial derived exosomes provide an important route for the 
exchange of proteins, lipids and nucleic acids that contribute to intercellular communication and 
regulation of the immune and cardiovascular systems 54,55. Endothelial cell derived exosomes are 
reported to directly modulate many different target cells, 47,56,57, and in turn endothelial cells are a 
target for exosomes released from other cells 58-61. For example, angiopoietin-2 (Ang2), an 
important regulator of vascular network formation, is secreted from endothelial cells on the outer 
surface of CD63-positive exosomes 47. While the etiology of these secreted exosomes has been 
assumed to be LE/MVBs, Ang2 can be stored in the lumen of WPBs for regulated secretion 62, 
raising the intriguing possibility that some of these vesicles may be released through WPB 
exocytosis.  
 Endothelial cells accumulate hundreds of WPBs under resting conditions and may contain 
similar numbers of MVBs 1,21. During Ca2+-stimulation WPB exocytosis is rapid in onset, peaking 
5-10 seconds after stimulation, involves up to 50% of the stored organelles and is largely complete 
within 1-2 minutes of stimulation 63. Ca2+-stimulated MVB fusion is reported to be slower in onset 
(2-6 minutes), involves a subpopulation of CD63+ MVBs 21,40,64 and is estimated to result in only a 
small fraction (~3%) of CD63+ MVB ILVs being released as exosomes 21. WPBs are therefore well 
placed for exosome release following acute cell activation and prior to exosome release by MVB-
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fusion. 
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Figure 1. CD63 is enriched in micro domains on WPBs.  
A-B; Confocal images of single fixed HUVEC (A) immuno-labelled with specific antibodies to 
CD63 (green) and VWF (red) or (B) expressing exogenous EGFP-CD63 (green) and immuno-
labelled for VWF (red).  Scale bars are 10µm. Arrow heads indicate bright regions of CD63 (A) or 
EGFP-CD63 (B) closely associated with individual WPBs. Inset panels show on expanded scales 
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the fluorescence, in grey scale, for VWF (left) and CD63 (middle) and the colour merge image 
(right; VWF in red, CD63 in green) for WPBs indicated by a and b. Images A and B were taken at 
room temperature using a Leica SP2 confocal microscope and software (Mannheim, Germany) 
equipped with a PL APO100x 1.4NA objective. (Ci) Image from a live cell confocal fluorescence 
experiment of an EGFP-CD63 (green) and VWFpp-mRFP (red) co-expressing HUVEC showing 
two WPBs containing discrete bright micro-domains of EGFP-CD63 fluorescence. Intensity plots 
through the long axis of the upper WPB (white line) are shown below (green: CD63, red VWFpp). 
(Cii) Histogram of the fold increase in mean EGFP fluorescence intensity in micro-domains 
compared to non-micro-domain regions (bulk WPB membrane) for 50 WPBs. Mean micro-domain 
EGFP intensity was 2.5±0.7 fold (n=49 WPbs, range 1.4-4.1) that in the bulk membrane of the 
corresponding WPB. Images in C were taken at 37°C using a Leica SP5 with a HCX PL APO CS 
100.0x 1.46NA Oil objective, pinhole (airy) 1.5, zoom 30-35.5, scan speed 1400Hz in xyt 
acquisition mode.  
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Figure 2. Electron cryomicroscopy of frozen-hydrated HUVECs showing Weibel-Palade 
Bodies in cytoplasm. 
A-C 2D images of Weibel-Palade Bodies show internal density for VWF tubules. ILVs are 
indicated by triangular white arrows. Fourier transform of WPB interior in B shows helical layer 
lines for VWF (arrows). Scale bars are 200 nm. 
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Figure 3. Section of an electron cryotomogram of a frozen-hydrated endothelial cell showing 
region with Weibel-Plade bodies. ILV’s within Weibel-Palade bodies indicated by arrow. Scale 
bar is 200 nm. 
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Figure. 4. Tomogram sections of Weibel-Palade bodies containing ILVs along with structural 
models.  
Tomogram section with structural model consisting of WPB limiting model green, ILV membrane 
blue-green, VWF tubules yellow, and ILV internal content, red. (A) inset shows tomogram cross- 
section at location of red line. (B) WPB from an HHMEC with an ILV at the left side of the granule. 
The ILV contains internal content similar to cytoplasmic granules as shown in Supplementary 
Figure S4. (C) WPB in a HUVEC with kink in the middle where tubules have disrupted the 
paracrystalline order. The ILV contains density similar in size to cytosolic densities visible 
throughout tomogram section. Scale bars are 200 nm. 
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Figure 5. Tomogram section showing WPBs and MVBs. 
Tomogram section (right) shows WPBs and MVBs containing ILVs as indicated in structural model 
(left). 
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Figure 6 CD63 in WPB ILVs is of endosomal origin. (A) confocal fluorescence image of 
HUVEC incubated live in the presence of an extracellular TRITC-conjugated mouse anti-CD63 
antibody (red; 1:55 dilution, 24 h). The cells were fixed and immunolabelled with a specific 
antibody to VWFpp (green). Scale bar 20µm.  The region indicated by the white box is shown as 
grey scale inserts to illustrate the accumulation of extracellular applied TRITC-anti-CD63 in WPBs. 
(B-C) examples of the accumulation of extracellular applied TRITC-anti-CD63 in micro-domains in 
WPBs in control (B; mock transfected) or EGFP-CD63 transfected (C) HUVEC incubated live with 
the TRITC-anti-CD63 (red) and subsequently immunolabelled for VWFpp (blue) and EGFP-CD63 
(anti-GFP antibody, green). TRITC-anti-CD63 can be seen in bright micro-domains on WPBs that 
co-localised with EGFP-CD63 micro-domains. Scale bars 2µm.  
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Figure. 7. WPB EGFP-CD63 micro-domains are secreted as discrete particles during 
exocytosis. A-D show examples of image montages taken from dual colour live cell videos 
(Supplementary videos S8, S9, S10 and S11 respectively) of EGFP-CD63 (top panels, green in 
colour merge) and VWFpp-mRFP (middle panels) containing WPBs prior to (frame 1) and during 
(frames 2-9) exocytosis evoked by histamine stimulation (100µM).  Scale bars are 2µm.  In each 
case the WPB indicated by the arrow undergoes a morphological transition from rod to spheroid 
shape accompanied by expulsion of VWFpp-EGFP and release of the EGFP-CD63 ILV as a 
discrete particle. In examples A-C the EGFP-CD63 particle diffuses out of the field of view, in D 
the particle remains trapped within the patch of secreted VWF. Images were acquired sequentially 
on a wide field microscope equipped with an Olympus UPLSAPO 100x 1.4NA objective, OptoLED 
epifluorescence excitation system and Andor Ixon3 EMCCD camera operating at 30 frames per 
second. 
